[go: up one dir, main page]

BG103933A - 5-(2-етил-2н-тетразол-5-ил)-1-метил-1,2,3,6- тетрахидропиридин малеат - Google Patents

5-(2-етил-2н-тетразол-5-ил)-1-метил-1,2,3,6- тетрахидропиридин малеат

Info

Publication number
BG103933A
BG103933A BG103933A BG10393399A BG103933A BG 103933 A BG103933 A BG 103933A BG 103933 A BG103933 A BG 103933A BG 10393399 A BG10393399 A BG 10393399A BG 103933 A BG103933 A BG 103933A
Authority
BG
Bulgaria
Prior art keywords
ethyl
methyl
tetrazol
tetrahydropyridine
maleate
Prior art date
Application number
BG103933A
Other languages
English (en)
Inventor
Sommer Michael Bech
Ole Nielsen
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of BG103933A publication Critical patent/BG103933A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Изобретението се отнася до присъединителна сол наябълчена киселина на 2-етил-5-(1-метил-1,2,5,6-тетрахидро-3-пиридил)-2Н-тетразол, до фармацевтични състави, които съдържат присъединителната с киселина сол, и до използването й при лечението на смущения, предизвикани от дисфункция на ацетилхолиновата (АсСh) или мускариновата система.
BG103933A 1997-07-01 1999-11-30 5-(2-етил-2н-тетразол-5-ил)-1-метил-1,2,3,6- тетрахидропиридин малеат BG103933A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK78197 1997-07-01
PCT/DK1998/000294 WO1999001448A1 (en) 1997-07-01 1998-07-01 5-(2-ethyl-2h-tetrazol-5-y1)-1-methyl-1,2,3,6-tetrahydropyridine maleate

Publications (1)

Publication Number Publication Date
BG103933A true BG103933A (bg) 2000-07-31

Family

ID=8097489

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103933A BG103933A (bg) 1997-07-01 1999-11-30 5-(2-етил-2н-тетразол-5-ил)-1-метил-1,2,3,6- тетрахидропиридин малеат

Country Status (25)

Country Link
EP (1) EP0994869A1 (bg)
JP (1) JP2002507215A (bg)
KR (1) KR20010014297A (bg)
CN (1) CN1261361A (bg)
AR (1) AR013096A1 (bg)
AU (1) AU735751B2 (bg)
BG (1) BG103933A (bg)
BR (1) BR9810331A (bg)
CA (1) CA2293324A1 (bg)
CO (1) CO4940483A1 (bg)
EA (1) EA200000081A1 (bg)
HU (1) HUP0002876A2 (bg)
IL (1) IL133093A0 (bg)
IS (1) IS5278A (bg)
JO (1) JO2031B1 (bg)
MA (1) MA25138A1 (bg)
NO (1) NO996580L (bg)
PE (1) PE116099A1 (bg)
PL (1) PL337184A1 (bg)
SK (1) SK187399A3 (bg)
TN (1) TNSN98120A1 (bg)
TR (1) TR199903283T2 (bg)
UY (2) UY25069A1 (bg)
WO (1) WO1999001448A1 (bg)
ZA (1) ZA985498B (bg)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
CZ287441B6 (en) * 1995-11-06 2000-11-15 Lundbeck & Co As H Pharmaceutical preparation for treating traumatic lesion of brain

Also Published As

Publication number Publication date
AU735751B2 (en) 2001-07-12
EA200000081A1 (ru) 2000-08-28
PL337184A1 (en) 2000-08-14
TR199903283T2 (xx) 2000-06-21
JP2002507215A (ja) 2002-03-05
BR9810331A (pt) 2000-09-05
CA2293324A1 (en) 1999-01-14
ZA985498B (en) 1999-01-20
CO4940483A1 (es) 2000-07-24
UY25177A1 (es) 2000-12-29
NO996580D0 (no) 1999-12-30
SK187399A3 (en) 2000-06-12
PE116099A1 (es) 1999-11-23
UY25069A1 (es) 1998-12-21
AR013096A1 (es) 2000-12-13
CN1261361A (zh) 2000-07-26
NO996580L (no) 1999-12-30
MA25138A1 (fr) 2001-04-02
HUP0002876A2 (hu) 2001-06-28
EP0994869A1 (en) 2000-04-26
JO2031B1 (en) 1999-05-15
WO1999001448A1 (en) 1999-01-14
TNSN98120A1 (fr) 2005-03-15
IL133093A0 (en) 2001-03-19
IS5278A (is) 1999-11-30
AU8102098A (en) 1999-01-25
KR20010014297A (ko) 2001-02-26

Similar Documents

Publication Publication Date Title
DE69528823D1 (en) Morpholinwirkstoffvorläufer als tachykininreceptorantagonisten
MXPA04002982A (es) Derivados de pirrolidinona.
CA2297911A1 (en) Substituted 6-phenylphenanthridines
YU59098A (sh) Derivati spiro-piperidina, postupak njihovog dobijanja, njihova upotreba u proizvodnji leka korisnog za lečenje ili prevenciju bolova, upalnih procesa, migrene, povraćanja i postherpetične neuralgije i farmaceutski sastav koji ih sadrži
PT1053256E (pt) Anticorpos para o receptor de morte 4 (dr4) e utilizações destes
MY134806A (en) Cyclosporins
EP1808177A3 (en) Methods of treatment of mitochondrial disorders
ATE300533T1 (de) 1,2,3,4-tetrahydroisochinolin-derivate als urotensin ii rezeptor-antagonisten
BG102425A (bg) (метилсулфонил)фенил-2-(5н)-фуранони като инхибитори на циклооксигеназа-2
IL118544A0 (en) Substituted amino pyridyl and pyrimidine containing compounds
TR200000015T2 (tr) Bileşikler ve metodlar
HUT73807A (en) 5-ht1-like indole derivatives and pharmaceutical compositions containing them
CA2250569A1 (en) Novel phenanthridines substituted in the 6 position
EP2213302A3 (en) DR4 antibodies and uses thereof
EP0627221A3 (en) Substance P antagonists used to treat vomiting.
WO1999045098A3 (en) Delivery or proteins into eukaryotic cells with recombinant yersinia
BG105256A (bg) Мускаринови агонисти и антагонисти
BG105761A (bg) Заместени 2-арилимино хетероцикли и състави коитоги съдържат за използване като средства за свързване на прогестероновия рецептор
WO2001010408A3 (de) Wässrige arzneimittelformulierung von moxifloxacin oder salzen davon
KR100292396B1 (bg)
BG103933A (bg) 5-(2-етил-2н-тетразол-5-ил)-1-метил-1,2,3,6- тетрахидропиридин малеат
AP2000001946A0 (en) Form V1 5,6-Dichloro-2-(isopropylamino)-1-(B-L-Ribofuranosyl)-1H- benzimidazole.
NO991734L (no) Pyrazolinoner for behandling av potensforstyrrelser
YU46302A (sh) Supstituisani piroli
FR2710844B1 (fr) Composition pour le traitement ou la prévention de l'herpès.